GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential ...

The study, "The Triple Combination of Meropenem, Avibactam, and a Metallo-β-Lactamase Inhibitor Optimizes Antibacterial Coverage Against Different β-Lactamase Producers," has been published in ...

AbbVie has announced that the U.S. Food and Drug Administration (FDA) has approved EMBLAVEO (aztreonam and avibactam), as a ...

BLBLi: β-lactam/β-lactamase inhibitor; CB: Chronic bronchitis ... 250 q.d. × 4 d) A/C (875/125 b.i.d. × 10 d) UC: CC – 93.0 vs 90.1% (NS) G 9 d vs Ceft/Cef 11 d to hospital discharge ...

This marks the first approval of a fixed-dose intravenous monobactam/β-lactamase inhibitor combination antibiotic for this indication. AbbVie, a prominent player in the biotechnology industry with a ...